RT Book, Section A1 Boulton, Matthew L. A1 Wagner, Abram L. A2 Boulton, Matthew L. A2 Wallace, Robert B. SR Print(0) ID 1182675574 T1 Measles T2 Maxcy-Rosenau-Last Public Health & Preventive Medicine, 16e YR 2022 FD 2022 PB McGraw Hill PP New York, NY SN 9781259644511 LK accessmedicine.mhmedical.com/content.aspx?aid=1182675574 RD 2024/04/19 AB Measles is considered perhaps the most infectious disease known to humans, possibly equaled only by pertussis in its communicability.1,2 Measles was described and differentiated from smallpox by the Persian physician Al-Razi in the tenth century,3 but was not recognized as a viral disease until 1911, with the virus first successfully cultured in tissue in the late 1930s.4 In the prevaccine era, virtually every child became infected with measles. With increasing development and availability of vaccines in the 1960s, the incidence of disease decreased dramatically.5 Measles-containing vaccines were among the very first vaccines to be incorporated into the World Health Organization’s (WHO) Expanded Program on Immunization (EPI)—those recommended vaccines that every country should publicly promote and fund.6 The United States was able to achieve measles elimination (i.e., complete control of any endemic chain of transmission to < 12 months), in 1997.7 Today, all regions of the WHO have established target dates for measles elimination.8,9 However, recent years have seen striking increases in the number of measles cases, even in countries with historically robust immunization programs.10 Measles remains a sentinel disease whose emergence within a country may represent a failure of the government to provide timely vaccinations to all residents or an increase in vaccine hesitancy, a growing concern following the now-discredited study reporting a link between measles vaccination and autism.